MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Xu, Guangxian ^a,b   Zhang, Yilin ^a   Wei, Jun ^a   Jia, Wei ^a   Ge, Zhaohui ^a   Zhang, Zhaobo ^a   Liu, Xiaoming ^c  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c NINGXIA UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; HepG2; MAP2K3; miR 21; miRNA sponges

Indexed keywords

MESSENGER RNA; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME REPRESSION; FEMALE; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3 GENE; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPRESSOR GENE;

3' UNTRANSLATED REGIONS; BASE PAIRING; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MAP KINASE KINASE 3; MICRORNAS; RNA INTERFERENCE;

EID: 84885159090     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-469     Document Type: Article

References (42)

1. Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W. Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 2008, 29(7):1306-1311. 10.1093/carcin/bgn116, 18477647.
2. Sen CK, Roy S. miRNA: licensed to kill the messenger. DNA Cell Biol 2007, 26(4):193-194. 10.1089/dna.2006.0567, 17465885.
3. Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM, Bolondi L, Negrini M. MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008, 12(6A):2189-2204. 10.1111/j.1582-4934.2008.00533.x, 19120703.
4. Liu M, Jiang S, Lu Z, Young K, Li Y. Physiological and pathological functions of mammalian microRNAs. Comprehensive Toxicology 2010, 2:427-446.
5. Tagawa H, Ikeda S, Sawada K. Role of microRNA in the pathogenesis of malignant lymphoma. Cancer Sci 2013, 104:801-809. 10.1111/cas.12160, 23551855.
6. Feng Y, Chen X, Gao L. Knockdown of miR-21 as a novel approach for leukemia therapy. J Formos Med Assoc 2010, 109(9):621-623. 10.1016/S0929-6646(10)60101-5, 20879171.
7. Dey N, Das F, Ghosh-Choudhury N, Mandal CC, Parekh DJ, Block K, Kasinath BS, Abboud HE, Choudhury CG. microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion. PLoS One 2012, 7(6):e37366. 10.1371/journal.pone.0037366, 3368259, 22685542.
8. Liu CZ, Liu W, Zheng Y, Su JM, Li JJ, Yu L, He XD, Chen SS. PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma. Chin Med Sci J 2012, 27(2):65-72.
9. Motoyama K, Inoue H, Mimori K, Tanaka F, Kojima K, Uetake H, Sugihara K, Mori M. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol 2010, 36(5):1089-1095.
10. Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 2012, 27(4):1019-1026. 3583594, 22267008.
11. Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007, 282(19):14328-14336. 10.1074/jbc.M611393200, 17363372.
12. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133(2):647-658. 10.1053/j.gastro.2007.05.022, 17681183.
13. Zhu Q, Wang Z, Hu Y, Li J, Li X, Zhou L, Huang Y. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep 2012, 27(5):1660-1668.
14. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 2008, 28(17):5369-5380. 10.1128/MCB.00479-08, 2519720, 18591254.
15. Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol 2011, 21(6):401-416. 10.2188/jea.JE20100190, 22041528.
16. Min L, He B, Hui L. Mitogen-activated protein kinases in hepatocellular carcinoma development. Semin Cancer Biol 2011, 21(1):10-20. 10.1016/j.semcancer.2010.10.011, 20969960.
17. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Canc 2006, 6(9):674-687.
18. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001, 22(2):153-183. 10.1210/er.22.2.153, 11294822.
19. Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Canc 2009, 9(8):537-549.
20. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, Zucman-Rossi J. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008, 47(6):1955-1963. 10.1002/hep.22256, 18433021.
21. Jia M, Souchelnytskyi N, Hellman U, O'Hare M, Jat PS, Souchelnytskyi S. Proteome profiling of immortalization-to-senescence transition of human breast epithelial cells identified MAP2K3 as a senescence-promoting protein which is downregulated in human breast cancer. Proteomics Clin Appl 2010, 4(10-11):816-828.
22. Sirivatanauksorn Y, Tovikkai C. Comparison of staging systems of hepatocellular carcinoma. HPB Surg 2011, 2011:818217. 3132503, 21760664.
23. Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Curr Biol 2010, 20(19):R858-R861. 10.1016/j.cub.2010.08.052, 20937476.
24. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998, 95(5):2509-2514. 10.1073/pnas.95.5.2509, 19394, 9482916.
25. Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, et al. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2007, 2(5):1236-1247. 10.1038/nprot.2007.135, 17546019.
26. Armendariz-Borunda J, Bastidas-Ramirez BE, Sandoval-Rodriguez A, Gonzalez-Cuevas J, Gomez-Meda B, Garcia-Banuelos J. Production of first generation adenoviral vectors for preclinical protocols: amplification, purification and functional titration. J Biosci Bioeng 2011, 112(5):415-421. 10.1016/j.jbiosc.2011.07.018, 21856222.
27. Schroeder A, Mueller O, Stocker S, Salowsky R, Leiber M, Gassmann M, Lightfoot S, Menzel W, Granzow M, Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006, 7:3. 10.1186/1471-2199-7-3, 1413964, 16448564.
28. Balcells I, Cirera S, Busk PK. Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers. BMC Biotechnol 2011, 11:70. 10.1186/1472-6750-11-70, 3135530, 21702990.
29. Chen Y, Gelfond JA, McManus LM, Shireman PK. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 2009, 10:407. 10.1186/1471-2164-10-407, 2753550, 19715577.
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(9):e45. 10.1093/nar/29.9.e45, 55695, 11328886.
31. Wei J, Huang X, Zhang Z, Jia W, Zhao Z, Zhang Y, Liu X, Xu G. MyD88 as a target of microRNA-203 in regulation of lipopolysaccharide or Bacille Calmette-Guerin induced inflammatory response of macrophage RAW264.7 cells. Mol Immunol 2013, 55:303-309. 10.1016/j.molimm.2013.03.004, 23522925.
32. Zaman MS, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S, Majid S, Fukuhara S, Chang I, Arora S, et al. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One 2012, 7(11):e50203. 10.1371/journal.pone.0050203, 3506541, 23189187.
33. Li H, Li C, Dai R, Shi X, Xu J, Zhang J, Zhou X, Li Z, Luo X. Expression of acetylated histone 3 in the spinal cord and the effect of morphine on inflammatory pain in rats. Neural Regen Res 2012, 7(7):517-522.
34. Liu C, Yu J, Yu S, Lavker RM, Cai L, Liu W, Yang K, He X, Chen S. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol 2010, 53(1):98-107. 10.1016/j.jhep.2010.02.021, 20447717.
35. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT, Jiang J, Schmittgen TD, Patel T. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006, 130(7):2113-2129. 10.1053/j.gastro.2006.02.057, 16762633.
36. Zhu M, Wang N, Tsao SW, Yuen MF, Feng Y, Wan TS, Man K, Feng Y. Up-regulation of microRNAs, miR21 and miR23a in human liver cancer cells treated with Coptidis rhizoma aqueous extract. Exp Ther Med 2011, 2(1):27-32. 3440660, 22977465.
37. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108. 10.3322/canjclin.55.2.74, 15761078.
38. Li Y, Li W, Yang Y, Lu Y, He C, Hu G, Liu H, Chen J, He J, Yu H. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme. Brain Res 2009, 1286:13-18.
39. Yao Q, Xu H, Zhang QQ, Zhou H, Qu LH. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem Biophys Res Commun 2009, 388(3):539-542. 10.1016/j.bbrc.2009.08.044, 19682430.
40. Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467(7311):86-90. 10.1038/nature09284, 20693987.
41. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, Olson EN. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 2010, 18(3):282-293. 10.1016/j.ccr.2010.08.013, 2971666, 20832755.
42. Gurtner A, Starace G, Norelli G, Piaggio G, Sacchi A, Bossi G. Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function. J Biol Chem 2010, 285(19):14160-14169. 10.1074/jbc.M109.094813, 2863202, 20223820.